Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

NCT00058006

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +20 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Rush Cancer Institute at Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)

NCT00312975

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site Bentonville, Arkansas, United States
  • Research Site Fayetteville, Arkansas, United States
  • Research Site Orange, California, United States
  • Research Site Danbury, Connecticut, United States
View all 26 locations
View Trial Details
Completed

Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00217698

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Saint Claraspital AG Basel, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Inselspital Bern Bern, Switzerland
  • Kantonsspital Bruderholz Bruderholz, Switzerland
View all 14 locations
View Trial Details
Completed

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

NCT00088556

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Bay Area Cancer Research Group Concord, California, United States
  • East Bay Medical Oncology/Hematology Associates Concord, California, United States
  • Southwest Cancer Care Escondido, California, United States
  • Kaiser Permanente Medical Center Hayward, California, United States
View all 52 locations
View Trial Details

Related conditions